Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cfourps
    Junior Member
    • Jan 2014
    • 2

    #1

    Alternative splicing versus incomplete splicing?

    In cDNA generated from poly-A reverse transcription of RNA, is it possible that PCR will detect incompletely spliced mRNA? How does one differentiate between something that is a legit isoform and an incompletely spliced molecule?

    On amplifying using primers binding to the 5'UTR and the 3'UTR, I am seeing a faint longer band in addition to a band at the size I expected based on the predicted mature mRNA.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Yes, that can happen and the best way to determine if it's a different isoform or just incompletely spliced would be to look and see if the reading frame changes. If so, you likely have intron inclusion. If not, well, you still might but there's no real way to rule that out other than perhaps seeing if the result encodes a protein and if the protein works (though one could successfully argue that either not producing a protein or producing a non-functional protein could both be results of a properly spliced transcript).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Working...